Fermenta Biotech informs about outcome of board meeting

12 Aug 2022 Evaluate
Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on August 12, 2022 has approved the unaudited financial results for the quarter ended June 30, 2022 (Standalone and Consolidated) as enclosed. It enclosed the Limited Review Report dated August 12, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 11.15 am and concluded at 11.50 am.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

354.15 1.65 (0.47%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×